An individualized algorithm to predict mortality in COVID-19 pneumonia: a machine learning based study

M. Laino, E. Generali, T. Tommasini, G. Angelotti, A. Aghemo, A. Desai, Pierandrea Morandini, G. Stefanini, A. Lleo, A. Voza, V. Savevski
{"title":"An individualized algorithm to predict mortality in COVID-19 pneumonia: a machine learning based study","authors":"M. Laino, E. Generali, T. Tommasini, G. Angelotti, A. Aghemo, A. Desai, Pierandrea Morandini, G. Stefanini, A. Lleo, A. Voza, V. Savevski","doi":"10.5114/aoms/144980","DOIUrl":null,"url":null,"abstract":"Introduction Identifying SARS-CoV-2 patients at higher risk of mortality is crucial in the management of a pandemic. Artificial intelligence techniques allow one to analyze large amounts of data to find hidden patterns. We aimed to develop and validate a mortality score at admission for COVID-19 based on high-level machine learning. Material and methods We conducted a retrospective cohort study on hospitalized adult COVID-19 patients between March and December 2020. The primary outcome was in-hospital mortality. A machine learning approach based on vital parameters, laboratory values and demographic features was applied to develop different models. Then, a feature importance analysis was performed to reduce the number of variables included in the model, to develop a risk score with good overall performance, that was finally evaluated in terms of discrimination and calibration capabilities. All results underwent cross-validation. Results 1,135 consecutive patients (median age 70 years, 64% male) were enrolled, 48 patients were excluded, and the cohort was randomly divided into training (760) and test (327) groups. During hospitalization, 251 (22%) patients died. After feature selection, the best performing classifier was random forest (AUC 0.88 ±0.03). Based on the relative importance of each variable, a pragmatic score was developed, showing good performances (AUC 0.85 ±0.025), and three levels were defined that correlated well with in-hospital mortality. Conclusions Machine learning techniques were applied in order to develop an accurate in-hospital mortality risk score for COVID-19 based on ten variables. The application of the proposed score has utility in clinical settings to guide the management and prognostication of COVID-19 patients.","PeriodicalId":190584,"journal":{"name":"Archives of Medical Science : AMS","volume":"438 1","pages":"0"},"PeriodicalIF":0.0000,"publicationDate":"2022-01-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"7","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Archives of Medical Science : AMS","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.5114/aoms/144980","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 7

Abstract

Introduction Identifying SARS-CoV-2 patients at higher risk of mortality is crucial in the management of a pandemic. Artificial intelligence techniques allow one to analyze large amounts of data to find hidden patterns. We aimed to develop and validate a mortality score at admission for COVID-19 based on high-level machine learning. Material and methods We conducted a retrospective cohort study on hospitalized adult COVID-19 patients between March and December 2020. The primary outcome was in-hospital mortality. A machine learning approach based on vital parameters, laboratory values and demographic features was applied to develop different models. Then, a feature importance analysis was performed to reduce the number of variables included in the model, to develop a risk score with good overall performance, that was finally evaluated in terms of discrimination and calibration capabilities. All results underwent cross-validation. Results 1,135 consecutive patients (median age 70 years, 64% male) were enrolled, 48 patients were excluded, and the cohort was randomly divided into training (760) and test (327) groups. During hospitalization, 251 (22%) patients died. After feature selection, the best performing classifier was random forest (AUC 0.88 ±0.03). Based on the relative importance of each variable, a pragmatic score was developed, showing good performances (AUC 0.85 ±0.025), and three levels were defined that correlated well with in-hospital mortality. Conclusions Machine learning techniques were applied in order to develop an accurate in-hospital mortality risk score for COVID-19 based on ten variables. The application of the proposed score has utility in clinical settings to guide the management and prognostication of COVID-19 patients.
查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
预测COVID-19肺炎死亡率的个性化算法:一项基于机器学习的研究
识别死亡风险较高的SARS-CoV-2患者对于大流行管理至关重要。人工智能技术允许人们分析大量数据以发现隐藏的模式。我们的目标是基于高级机器学习开发和验证COVID-19入院时的死亡率评分。材料与方法对2020年3月至12月住院的成人COVID-19患者进行回顾性队列研究。主要终点是住院死亡率。基于重要参数、实验室值和人口特征的机器学习方法被应用于开发不同的模型。然后,进行特征重要性分析,以减少模型中包含的变量数量,形成一个整体性能良好的风险评分,最后根据区分和校准能力对其进行评估。所有结果进行交叉验证。结果连续入组1135例患者(中位年龄70岁,男性64%),排除48例患者,随机分为训练组(760例)和试验组(327例)。在住院期间,251例(22%)患者死亡。经过特征选择后,表现最好的分类器为随机森林(AUC为0.88±0.03)。根据每个变量的相对重要性,制定了实用评分,表现良好(AUC为0.85±0.025),并定义了三个与住院死亡率相关的水平。结论应用机器学习技术基于10个变量建立准确的COVID-19住院死亡风险评分。该评分的应用在临床环境中具有指导COVID-19患者管理和预后的效用。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
自引率
0.00%
发文量
0
期刊最新文献
Clinical validation of superior vena cava respiratory variation in predicting fluid responsiveness using transthoracic echocardiography technique: a pilot study. Heterologous high dose SARS-CoV-2 mRNA vaccine booster may improve immune response in seronegative kidney transplant recipients. Primary Sjögren's syndrome combined with Chlamydia psittaci infection. One case of comprehensive treatment for advanced liver cancer followed up over three years. The overall benefits of empagliflozin treatment in adult siblings with glycogen storage disease type Ib: one year experience.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1